After Failed Alzheimers Study, Sage Therapeutics Dalzanemdor Flunks Another Study In Patients With Inherited Brain Disorder
| DMCYX Fund | USD 35.65 0.10 0.28% |
Slightly above 67% of Dreyfus Opportunistic's investor base is looking to short. The analysis of overall sentiment of trading Dreyfus Opportunistic Midcap mutual fund suggests that many investors are alarmed at this time. Dreyfus Opportunistic's investing sentiment can be driven by a variety of factors including economic data, Dreyfus Opportunistic's earnings reports, geopolitical events, and overall market trends.
Dreyfus |
Sage Therapeutics ends dalzanemdor development after Phase 2 trials for Huntingtons and Alzheimers fail to meet primary endpoints.
Read at benzinga.com
 |
Dreyfus Opportunistic Fundamental Analysis
We analyze Dreyfus Opportunistic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dreyfus Opportunistic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dreyfus Opportunistic based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Dreyfus Opportunistic is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Dreyfus Opportunistic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dreyfus Opportunistic mutual fund to make a market-neutral strategy. Peer analysis of Dreyfus Opportunistic could also be used in its relative valuation, which is a method of valuing Dreyfus Opportunistic by comparing valuation metrics with similar companies.
Peers
Dreyfus Opportunistic Related Equities
| AUERX | Auer Growth | 0.23 | ||||
| TWBIX | Balanced Fund | 0.1 | ||||
| BOSVX | Omni Small-cap | 0.14 | ||||
| USCAX | Small Cap | 0.20 | ||||
| VOLMX | Volumetric Fund | 0.45 | ||||
| LIOTX | Issachar Fund | 0.66 |
Other Information on Investing in Dreyfus Mutual Fund
Dreyfus Opportunistic financial ratios help investors to determine whether Dreyfus Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dreyfus with respect to the benefits of owning Dreyfus Opportunistic security.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |